Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Aksys, Ltd. (NasdaqNM:AKSY)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Options | Financials
Location
Two Marriott Drive
Lincolnshire, IL 60069
Phone: (847) 229-2020
Fax: (847) 229-2080
Email: invrel@aksys.com
Employees (last reported count): 94
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Medical Equipment & Supplies
Company Websites
 ·Home Page
 ·Investor Relations
 ·Employment
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 46%
·Over the last 6 months:
 · 2 insider sells; 57.0K shares
  (0.7% of insider shares)
·Institutional: 33% (60% of float)
(56 institutions)
·Net Inst. Selling: 513.0K shares (+9.27%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Aksys, Ltd. provides hemodialysis products and services for patients suffering from end-stage renal disease (ESRD), known as chronic kidney failure. The Company has developed an automated personal hemodialysis system, known as the Aksys PHD Personal Hemodialysis System (the PHD System), which is designed to enable patients to perform frequent hemodialysis at alternate sites, such as the patient's home, and to thereby improve clinical outcomes, reduce total ESRD treatment costs and enhance the patients' quality of life. All of these characteristics have been associated with frequent hemodialysis. The Company is working toward satisfying the regulatory requirements for Food and Drug Administration clearance to market the PHD System in the United States. The Company completed a clinical evaluation of the PHD System in November 2000. In January 2001, Aksys submitted a 510(k) pre-market notification for clearance to market the PHD System.
More from Market Guide: Expanded Business Description

Financial Summary
Aksys, Ltd. is a development stage company working to provide hemodialysis products and services for patients suffering from end stage renal disease (ESRD), commonly known as chronic kidney failure. For the six months ended 6/30/01, revenues totaled $0, down from $2 million. Net loss rose 24% to $9.1 million. Revenues reflect the absence of a $2 million joint development income. Higher loss was partially offset by lower research and development expenses.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Pay

Richard Egen, 62
Chairman
--  
William Dow, 54
Pres, CEO, Director
$461K
Dennis Erwin
Sr. VP, CFO
--  
Richard Goldhaber
Sr. VP, CTO
287K
David Bellitt
Sr. VP of Sales and Marketing
--  
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:AKSYAs of 31-Aug-2001
Price and Volume
52-Week Low
on 4-Apr-2001
$3.625
Recent Price$6.00 
52-Week High
on 5-Oct-2000
$17.50 
Beta0.77 
Daily Volume (3-month avg)43.7K
Daily Volume (10-day avg)33.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y]
52-Week Change-45.5%
52-Week Change
relative to S&P500
-26.8%
Share-Related Items
Market Capitalization$111.2M
Shares Outstanding18.5M
Float10.0M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$0.58 
Earnings (ttm)-$0.97 
Earnings (mrq)-$0.27 
Sales (ttm)$0.08 
Cash (mrq)$0.21 
Valuation Ratios
Price/Book (mrq)10.38 
Price/EarningsN/A 
Price/Sales (ttm)76.84 
Income Statements
Sales (ttm)$1.41M
EBITDA (ttm)-$17.3M
Income available to common (ttm)-$17.5M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-84.94%
Return on Equity (ttm)-99.84%
Financial Strength
Current Ratio (mrq)3.08 
Debt/Equity (mrq)0 
Total Cash (mrq)$3.87M
Short Interest
As of 8-Aug-2001
Shares Short83.0K
Percent of Float0.8%
Shares Short
(Prior Month)
140.0K
Short Ratio3.19 
Daily Volume26.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.